Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172168 | SCV000051096 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Ambry Genetics | RCV000244016 | SCV000318494 | uncertain significance | Cardiovascular phenotype | 2013-03-06 | criteria provided, single submitter | clinical testing | There is insufficient or conflicting evidence for classification of this alteration. |
Phosphorus, |
RCV000577929 | SCV000679969 | uncertain significance | Dilated cardiomyopathy 1G | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000578003 | SCV000679970 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000578083 | SCV000679971 | uncertain significance | Tibial muscular dystrophy | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000172168 | SCV000714308 | likely benign | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23861362) |
Labcorp Genetics |
RCV001078580 | SCV000765049 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000600352 | SCV001919594 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000172168 | SCV001968298 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004535169 | SCV004746347 | likely benign | TTN-related disorder | 2020-03-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |